These results demonstrated that the protein expression of CALM1 increases in breast cancer, liver cancer, and pancreatic cancer, but decreases in colorectal cancer, prostate cancer, and lung cancer, compared with that in normal tissues, which is consistent with the mRNA levels of CALM1. This evidence concerns the gene CALM1 and prostate carcinoma.